Stocklytics Platform
Asset logo for symbol OMER
Omeros
OMER47
$9.89arrow_drop_down3.04%-$0.31
Asset logo for symbol OMER
OMER47

$9.89

arrow_drop_down3.04%

Performance History

Chart placeholder
Key Stats
Open$10.02
Prev. Close$10.17
EPS-3.14
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range9.73
10.56
52 Week Range0.92
13.57
Ratios
Revenue-
EBITDA Margin %-
EPS-3.14

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Omeros (OMER)

Omeros Corp (OMER) is a biopharmaceutical company that focuses on discovering, developing, and commercializing small-molecule and protein therapeutics for various diseases and conditions. The company's primary product is OMIDRIA, an FDA-approved drug used during cataract surgery or intraocular lens replacement. OMIDRIA is designed to maintain pupil size and reduce postoperative pain and inflammation. Omeros Corp has been working on expanding the use of OMIDRIA to other indications to further drive its revenue growth.
In terms of stock performance, Omeros Corp has had a volatile history. The stock price has experienced significant fluctuations over the past years, with periods of both price surges and declines. Investors should carefully consider the company's financial performance and outlook before making investment decisions.
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Gregory A. Demopulos M.D.
Headquarters
Seattle
Employees
196
Exchange
NASDAQ
add Omeros to watchlist

Keep an eye on Omeros

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Omeros (OMER) stock price performance year to date (YTD)?

As of the latest data, Omeros (OMER) has a year-to-date price change of 0.1%. Over the past month, the stock has experienced a price change of -13.09%. Over the last three months, the change has been 154.24%. Over the past six months, the figure is 154.24%. Looking at a longer horizon, the five-year price change stands at -26.03%.
help

What is the market capitalization of Omeros (OMER)?

Omeros (OMER) has a market capitalization of $573.12M. The average daily trading volume is 9.92, indicating the stock's liquidity and investor engagement.
help

What is Omeros's (OMER) price per share?

The current price per share for Omeros (OMER) is $9.89. The stock has seen a price change of -$0.31 recently, indicating a -3.05% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Omeros (OMER)?

For Omeros (OMER), the 52-week high is $13.57, which is 37.22% from the current price. The 52-week low is $0.92, the current price is 975% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Omeros (OMER) a growth stock?

Omeros (OMER) has shown an average price growth of -1.65% over the past three years. It has received a score of 86 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Omeros as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

Is Omeros (OMER) a profitable company?

Omeros (OMER) has a net income of -$117.81M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$164.53M. Furthermore, the EBITDA is -$172.51M.

Take Your Investments to a Whole New Level